feed,title,long_url,short_url
Benzinga,AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s),https://benzinga.com/general/biotech/22/05/27259695/astrazeneca-in-licenses-new-suite-of-covid-19-antibody-candidate-s,https://bit.ly/3LoWha2
Benzinga,"Alibaba, Other Chinese Stocks Pop As China's Top Economic Official Expresses Support For Digital Platform Ahead Of 2022 Election",https://benzinga.com/government/22/05/27255019/alibaba-other-chinese-stocks-pop-as-chinas-top-economic-official-expresses-support-for-digital-platf,https://bit.ly/3wn8sji
